Gene signature found for poor response to standard chemotherapy in rare uterine cancer
Women who don't survive a rare and aggressive uterine cancer called uterine serous carcinoma, have high expression of a group of 73 genes, a score scientists say can help identify these women and improve their outcome.
Apr 22, 2020
0
60